ReviewFrontiers in immunology2026

Navigating the gut-metabolite-immune axis: enhancing efficacy and mitigating toxicity of immune checkpoint inhibitors.

Yu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.